Cite

HARVARD Citation

    Haney, M. et al. (2020). Do DPP-4 inhibitors have compelling patient-oriented benefits in the treatment of type 2 diabetes mellitus?. Evidence-based practice. 23 (6), p. 21. [Online]. 
  
Back to record